Zeeya Merali in Nature:
Five scientists who contributed to the development of the blockbuster weight-loss drugs Ozempic and Wegovy have picked up one of this year’s US$3-million Breakthrough prizes — the most lucrative awards in science.
Originally developed to treat diabetes, these drugs work by mimicking a hormone called glucagon-like peptide 1 (GLP-1) that controls blood sugar levels and helps to curb appetite. “This class of drugs truly saves lives, changes lives and brings joy back to people’s lives,” says Ziyad Al-Aly, a physician-scientist at the Veterans Affairs St. Louis Health Care System in Missouri, who recently led a massive study analysing data from almost two million people to evaluate the effects of such medication1.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.